Acute Myeloblastic Leukemia with Maturation

Search Trials
Development and Application of a Novel Digital Array PCR for Acute Myeloid Leukemia (AML)
Status:
Recruiting
Last Changed:
Jun 11, 2021
First Changed:
Jun 9, 2021
Disease(s):
Leukemia, Myeloid, Acute
Development and Exploration of the Feasibility of Using Locally Synthesized Small Molecule Inhibitors to Treat Human Acute Leukemia Cells
Status:
Unknown status
Last Changed:
Jun 11, 2010
First Changed:
Jun 11, 2010
Disease(s):
Acute Myeloid Leukemia
ALT-801-activated Natural Killer Cells After FLAG Induction for Acute Myeloid Leukemia
Status:
Withdrawn
Last Changed:
Jan 3, 2014
First Changed:
Nov 23, 2011
Disease(s):
Acute Myeloid Leukemia
Intervention(s):
G-CSFCytarabineFludarabineDonor Natural Killer (NK) cellsALT-801
High Dose Chemotherapy, Peripheral Stem Cell Transplantation, and Interleukin-2 in Treating Patients With Acute Myeloid Leukemia
Status:
Completed
Last Changed:
Apr 13, 2012
First Changed:
Apr 16, 2003
Disease(s):
Leukemia
Intervention(s):
aldesleukinfilgrastimcyclophosphamidecytarabineetoposideidarubicinmelphalanperipheral blood stem cell transplantationradiation therapy
A Phase I/II Study of Induction Chemotherapy With Daunorubicin, Cytarabine, Topotecan and Etoposide
Status:
Completed
Last Changed:
Sep 25, 2012
First Changed:
May 7, 2003
Disease(s):
Leukemia
Intervention(s):
CytarabineDaunorubicinEtoposideTopotecan

Connect. Empower. Inspire.